---
trial_id: 736
discovery_date: 2022-04-25 18:10:06.804005
date: 2022-04-25 18:10:06.804005
title: "A NIS Evaluating Injectable Treatments in Patients With Relapsing Multiple Sclerosis"
summary: |
  <b>Condition</b>:    Relapsing Multiple Sclerosis<br /><b>Interventions</b>:    Other: ofatumumab;   Other: glatiramer acetate;   Other: interferon β1<br /><b>Sponsor</b>:    Novartis Pharmaceuticals<br /><b>Not yet recruiting</b>
link: 'https://clinicaltrials.gov/ct2/show/NCT05344469?cond=Multiple+Sclerosis&sfpd_d=14&sel_rss=new14'
published_date: 2022-04-25 16:00:00
trial_source: ClinicalTrials.gov
relevant: 
options:
  unlisted: false
---
<b>Condition</b>:    Relapsing Multiple Sclerosis<br /><b>Interventions</b>:    Other: ofatumumab;   Other: glatiramer acetate;   Other: interferon β1<br /><b>Sponsor</b>:    Novartis Pharmaceuticals<br /><b>Not yet recruiting</b>